Re-Covr InjectionThis page contains information on Re-Covr Injection for veterinary use.
The information provided typically includes the following:
- Re-Covr Injection Indications
- Warnings and cautions for Re-Covr Injection
- Direction and dosage information for Re-Covr Injection
Re-Covr InjectionThis treatment applies to the following species:
TRIPELENNAMINE HYDROCHLORIDE INJECTION
ANADA 200-162, Approved by FDA
Re-Covr Injection Caution:
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Tripelennamine hydrochloride is a white, crystalline material which is stable, nonhygroscopic and readily soluble in water. It is supplied in multiple dose vials containing 20 mg of Tripelennamine Hydrochloride USP per mL.
Tripelennamine hydrochloride is characterized by its capacity to antagonize many of the pharmacologic effects of histamine.
Re-Covr Injection Indications
For use in cattle and horses in conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.
Do not use in horses intended for food purposes.
Milk that has been taken during treatment and for 24 hours (two milkings) after the last treatment must not be used for food.
Treated cattle must not be slaughtered for food during treatment and for four days following the last treatment.
WARNING: A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
Re-Covr Injection Caution
Central nervous system stimulation in the form of hyperexcitability, nervousness and muscle tremors lasting up to 20 minutes have been noted in horses, particularly following intravenous administration; therefore, only the intramuscular route of administration should be used in horses.
Overdosage of tripelennamine hydrochloride may give rise to excitement, ataxia and convulsions.
Depression of the central nervous system and incoordination may occur when the drug is used at therapeutic dose levels.
Disturbances in gastrointestinal function may occur in some instances.
While poisonous snake bites have been treated with antihistaminic drugs, other conjunctive therapy is required because of toxic reactions associated with the protein complex of venom.
Re-Covr Injection Dosage And Administration
Warm the solution to near body temperature. Using aseptic precautions, administer intravenously or intramuscularly as specified below. Intramuscular injections should be made into the heavy musculature of the hind leg or cervical area.
The doses specified below may be repeated in 6 to 12 hours if necessary.
Cattle - Administer intravenously or intramuscularly at a dose of 0.5 mg per lb of body weight (2.5 mL for each 100 lbs of body weight). For a more rapid onset of action, the intravenous route of administration is recommended.
Horses - Administer intramuscularly only at a dose of 0.5 mg per lb of body weight (2.5 mL for each 100 lbs of body weight).
Re-Covr Injection (Tripelennamine Hydrochloride Injection) is supplied in 250 mL and 500 mL multiple dose vials containing 20 mg Tripelennamine Hydrochloride USP per mL.
Protect from light. Store between 15°C and 30°C (59°F-86°F). Avoid excessive heat (104°F).
© 2007 Fort Dodge Animal Health. All Rights Reserved.
Fort Dodge Animal Health, Fort Dodge, Iowa 50501 USA
NAC No.: 10031827
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Customer Service:||800-733-5500 and 800-793-0596|
|Veterinary Medical Investigations & Product Support:||800-366-5288|
|Technical Services (USA):||800-366-5288|
|Every effort has been made to ensure the accuracy of the Re-Covr Injection information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2013 North American Compendiums. Updated: 2013-09-18